Related Experiment Video
Updated: Nov 18, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pertussis in infants in Nordic countries
Amit Bhavsar1, Jussi Mertsola2, Anja Poulsen3
1Epidemiology & Health Economics, GSK, Wavre, Belgium.
Insights
A life-course immunization strategy is crucial for pertussis control. Higher infant pertussis incidence in Denmark may stem from lacking adolescent booster vaccine recommendations, unlike other Nordic countries.
Area of Science:
- Public Health
- Epidemiology
- Immunization Practices
Background:
- Pertussis (whooping cough) remains a significant public health concern, particularly for infants.
- Effective control requires a comprehensive life-course immunization approach.
- Understanding pertussis incidence in relation to vaccination strategies is vital for Nordic countries.
Purpose of the Study:
- To review pertussis incidence among infants in Denmark, Finland, Norway, and Sweden (2014-2018).
- To analyze national surveillance systems and infant vaccination schedules.
- To contextualize pertussis incidence within existing immunization policies.
Main Methods:
- Collected data on pertussis incidence, vaccination schedules, and DTaP vaccine coverage (infancy).
- Utilized publicly available data sources and expert opinions on national surveillance.
- Compared vaccination schedules, including adolescent boosters and maternal immunization recommendations.
Main Results:
- Infant vaccination schedules and DTaP vaccine coverage were similar across the four Nordic countries.
- Denmark, Sweden, and Finland reported mean pertussis incidences of 168, 76, and 35 per 100,000 infant-years, respectively.
- Adolescent booster recommendations were present in all countries except Denmark; maternal immunization was not recommended in any.
Conclusions:
- The higher pertussis incidence in Denmark may be linked to the absence of adolescent booster vaccination recommendations.
- National surveillance systems showed no systematic differences across the studied countries.
- Further research is warranted to investigate the impact of adolescent boosters on pertussis control.
Aim:
A life-course immunisation approach is required to prevent and control pertussis. We aimed at reviewing pertussis incidence among infants in Denmark, Finland, Norway and Sweden, and at putting these data in the context of national surveillance systems and vaccination schedules.
Methods:
We collected 2014-2018 data on pertussis incidence, on pertussis vaccination schedules and on coverage of the third dose of the diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine from publicly available sources. We gathered opinions on national surveillance systems from public health and paediatrics experts of the relevant countries.
Results:
The pertussis vaccination schedules and coverage in infancy were similar across countries. All countries except Denmark recommended an additional booster vaccine dose for adolescents. None of the countries had maternal immunisation recommendation. Mean pertussis incidence in Denmark, Sweden and Finland was 168, 76 and 35 per 100,000 infant-years, respectively. Data were insufficient to derive a mean incidence in Norway. There were no systematic differences in the national surveillance systems across the countries.
Conclusion:
The higher mean pertussis incidence in Denmark may be explained by the lack of recommendations for adolescent pertussis booster vaccination. Further investigations are warranted.
More Related Videos
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Vaccinations
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Cycle: Exhalation
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...